Calcium and Cardiovascular Disease: The Latest Evidence Report
Dr. Andrea Singer presented at the Academy of Nutrition and Dietetics’ Food and Nutrition Conference and Expo (FNCE) in Boston, MA, on October 16, 2016. She shared the research and joint position statement from the National Osteoporosis Foundation (NOF) and the American Society of Preventative Cardiology (ASPC) on lack of evidence linking calcium intake and cardiovascular disease. Attached is her presentation. This presentation cannot be copied or used without written permission from NOF.
Calcium and Cardiovascular Disease: The Latest Evidence Report
Originally held:
October 16, 2016 at FNCE Expo Hall Learning Center

Faculty:
Andrea J. Singer, MD, FACP, CCD
Director, Women's Primary Care
Director, Bone Densitometry
Department of Obstetrics and Gynecology
MedStar Georgetown University Hospital
Disclosures: Board/Scientific Advisory Committees: National Osteoporosis Foundation and Clinical Director; Employer: MedStar Georgetown University Hospital

Cost: Free

Activity Description

Dr. Andrea Singer presented at the Academy of Nutrition and Dietetics’ Food and Nutrition Conference and Expo (FNCE) in Boston, MA, on October 16, 2016.  She shared the research and joint position statement from the National Osteoporosis Foundation (NOF) and the American Society of Preventative Cardiology (ASPC) on lack of evidence linking calcium intake and cardiovascular disease. Attached is her presentation. This presentation cannot be copied or used without written permission from NOF.

Learning Objectives

1. Relate the importance of calcium intake for optimal bone health and physiologic functioning.

2. Summarize the effect of calcium supplementation on cardiovascular events.

3. List the proper safe dosage and indications for calcium supplementation.


Acknowledgement of Funding:  Funding from Pfizer Consumer Healthcare was received by the National Osteoporosis Foundation (NOF) for the educational symposium. Support for the Scientific Evidence Report was provided through an unrestricted educational grant from the National Osteoporosis Foundation (NOF) through the support of Pfizer Consumer Healthcare.

Type:     Internet Activity (Enduring Material)
69 Registered Users

National Osteoporosis Foundation

251 18th Street South, Suite 630, Arlington, VA 22202 I [p] 1 (800) 231-4222 • [f] 1 (703) 414-3742

The National Osteoporosis Foundation is a qualified 501(c)(3) tax-exempt organization and all donations to the organization are
tax deductible to the full extent allowable by law. NOF’s tax ID number is 36-3350532.